JSC is a leading game development company, providing premium quality game art and game development services to publishers and game developers since 2011. We are a tight cluster of seasoned producers, game developers, and artists.
Our vision is making your vision a reality.
JSC-Seven Point One to sign a partnership for the development of new digital drugs.
JSC (CEO Park Ji-young) signed a strategic partnership with Seven Point One (CEO Lee Hyun-joon) to jointly develop and cooperate with each other in digital new drugs.
Digital new drugs refer to digital treatments in the form of software, such as virtual reality medical devices, games and the presentation of optimal treatments using big data. Digital new drugs are expected to be used in the treatment of diabetes and high blood pressure, leading to changes in users' lifestyle and behavior, including Alzheimer's, autism and other diseases known as intractable diseases.
Through the partnership, the two companies agreed to cooperate in all areas, including research, planning and development of new digital drugs with promising future prospects. It has decided to share networks of both companies when entering domestic and foreign markets. It will also actively pursue joint partnerships with other institutions and companies interested in developing new digital drugs to seek ultra-agency cooperation in market exploration.
Park Ji-young, CEO of JSC, said, "We will try to become a partnership that will advance the globalization of digital new drugs by utilizing the game development capabilities that JS has accumulated, VR, interactive augmented reality (AR) technology, and overseas export experiences such as China."
Full cycle game production